User profiles for Ravindra K. Gupta
Ravindra Kumar GuptaUniversity of Cambridge Verified email at cam.ac.uk Cited by 25815 |
[HTML][HTML] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
…, IG Goodfellow, NJ Matheson, K Sato, RK Gupta - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
[HTML][HTML] SARS-CoV-2 variants, spike mutations and immune escape
Although most mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
genome are expected to be either deleterious and swiftly purged or relatively neutral, a …
genome are expected to be either deleterious and swiftly purged or relatively neutral, a …
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok… - Nature, 2019 - nature.com
A cure for HIV-1 remains unattainable as only one case has been reported, a decade ago 1
, 2 . The individual—who is known as the ‘Berlin patient’—underwent two allogeneic …
, 2 . The individual—who is known as the ‘Berlin patient’—underwent two allogeneic …
[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
[HTML][HTML] The biological and clinical significance of emerging SARS-CoV-2 variants
The past several months have witnessed the emergence of SARS-CoV-2 variants with novel
spike protein mutations that are influencing the epidemiological and clinical aspects of the …
spike protein mutations that are influencing the epidemiological and clinical aspects of the …
The “silent” global burden of congenital cytomegalovirus
Human cytomegalovirus (CMV) is a leading cause of congenital infections worldwide. In the
developed world, following the virtual elimination of circulating rubella, it is the commonest …
developed world, following the virtual elimination of circulating rubella, it is the commonest …
[PDF][PDF] Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75
…, X Niu, Q Gu, F Shao, X Hao, B Meng, RK Gupta… - Cell host & …, 2022 - cell.com
Recently emerged SARS-CoV-2 Omicron subvariant, BA.2.75, displayed a growth advantage
over circulating BA.2.38, BA.2.76, and BA.5 in India. However, the underlying mechanisms …
over circulating BA.2.38, BA.2.76, and BA.5 in India. However, the underlying mechanisms …
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
…, RK Gupta… - Science, 2021 - science.org
Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…
[HTML][HTML] SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
Monoclonal antibodies (mAbs) offer a treatment option for individuals with severe COVID-19
and are especially important in high-risk individuals where vaccination is not an option. …
and are especially important in high-risk individuals where vaccination is not an option. …
[HTML][HTML] FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting
enzyme 2 (ACE2) 1 , could represent a new chemoprophylactic approach for …
enzyme 2 (ACE2) 1 , could represent a new chemoprophylactic approach for …